Wentworth Kory Jamesinsider trades
In SEC Form 4 filings, Wentworth Kory James is listed as Chief Financial Officer of Entrada Therapeutics, Inc. (TRDA). Wentworth Kory James reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | Chief Financial Officer | 1 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.